AIZ vs APLS · P/E 15, rev $3.45B vs rev $1.00B
Assurant Inc (AIZ) versus Apellis Pharmaceuticals Inc (APLS) — a side-by-side from cached financials, not a winner call.
Assurant Inc (AIZ) is a insurance - property & casualty company listed on US.
Apellis Pharmaceuticals Inc (APLS) is a biotechnology company listed on US.
Latest reported AIZ revenue for 2026-06-30 was $3.45B. Net income was $298.6M. Revenue was up 1.0% from 2026-03-31 to 2026-06-30. AIZ currently screens at market cap $9.98B and trailing P/E 15.4.
Latest reported APLS revenue for 2025-12-31 was $1.00B. Net income was $22.4M. Revenue was up 28.5% from 2024-12-31 to 2025-12-31. APLS currently screens at market cap $2.29B.
AIZ currently screens at market cap $9.98B and trailing P/E 15.4. APLS currently screens at market cap $2.29B.
Not investment advice. Open the AIZ and APLS stock pages for the full models.
Not investment advice.